Embla Medical hf. (CPH: EMBLA)
Denmark
· Delayed Price · Currency is DKK
34.50
0.00 (0.00%)
At close: Dec 20, 2024
Embla Medical Revenue
Embla Medical had revenue of $213.53M USD in the quarter ending September 30, 2024, with 10.68% growth. This brings the company's revenue in the last twelve months to $840.31M, up 9.64% year-over-year. In the year 2023, Embla Medical had annual revenue of $785.68M with 9.33% growth.
Revenue (ttm)
$840.31M
Revenue Growth
+9.64%
P/S Ratio
2.63
Revenue / Employee
$210.13K
Employees
3,999
Market Cap
14.73B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
Dec 31, 2022 | 718.65M | -19.00K | -0.00% |
Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
Dec 31, 2020 | 629.50M | -56.76M | -8.27% |
Dec 31, 2019 | 686.26M | 73.39M | 11.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 270.58B |
Coloplast A/S | 27.03B |
Genmab A/S | 19.84B |
Zealand Pharma A/S | 76.87M |
Demant A/S | 22.84B |
H. Lundbeck A/S | 21.44B |
H. Lundbeck A/S | 21.44B |
ALK-Abelló A/S | 5.38B |